THAMBIPILLAI SURESHKUMAR: Open Payments
NPI 1134211253 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$113 in 4 payments from 4 companies in 2025. Trend: 2023 $117 · 2024 $171 · 2025 $113
Food & beverage: $113
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 1 | $42 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Luye Pharma (USA) Ltd. | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: INVEGA SUSTENNA, ABILIFY ASIMTUFII, ERZOFRI EXTENDED-RELEASE, COBENFY.
Industry payments across PA — which companies pay providers there.
